abstract
Characterization of host microbial interactions typically occurs on the cellular or protein level. Recently, a more thorough and accurate appreciation of cellular interactions has come into better focus with improved understanding of membrane vesicles (OMV). While OMVs are documented primarily in Gram-negative bacteria, certain Gram-positive species generate these structures, despite the obvious physical limitations of the cell envelope. Here, we briefly review the current understanding of OMVs in content and function, their role in pathogenesis, and the consequences of somatic cell gene expression on these events.
KEYWORDS: bacteria, immunity, membrane, pathogenesis, vesicles
The Gram–negative bacterial envelope is a heterogeneous mixture of proteins, lipids, and complex glycolipids consisting of outer and inner membranes surrounding a thin and flexible peptidoglycan cell wall. OMV formation in Gram-negative bacteria is highly dependent on the state of crosslinking and molecular interactions between several proteins of the outer membrane and the peptidoglycan layer.1 Interactions between the peptidoglycan cell wall and Braun's lipoprotein (Lpp), outer-membrane protein A (OmpA), or the peptidoglycan-associated lipoprotein complex (Tol-Pal) are well characterized interactions central to membrane stability and rate of vesicle release.1 Functional impairment or deletion of Lpp, OmpA, or Tol-Pal resulted in increased membrane volatility and hyper-vesiculation. Alterations to membrane stabilizing crosslinking events can be coordinated locally or globally by specific cellular responses to environmental factors, signaling pathways, or other undefined perturbations.2-5 The importance of outer membrane lipid composition and asymmetry was highlighted by the hyper-vesiculation observed after disruption of the VacJ/Yrb ATP-binding cassette (ABC) transport system in Haemophilus influenzae, Vibrio cholerae, and Escherichia coli without compromising the outer membrane integrity.6 This transport system is purported to traffic phospholipids to the outer membrane, and its expression is down regulated during iron limiting environments.6 This is an important observation as it strongly links OMV production to environmental conditions likely encountered during the pathogenic lifecycle of H. influenzae, as well as other Gram–negative bacteria.
OMV release in Gram-negative bacteria is ubiquitous and associated with all facets of bacterial physiology including division, nutrient acquisition, toxin sequestration, antibiotic removal, formation and maintenance of bacterial communities/biofilms, cargo packaging and release – including delivery of virulence factors and pro-inflammatory molecules to host cells.1 One of the earliest OMV observations came from a study of Vibrio cholerae vegetative cultures in which “approximately spherical sacs” were observed blebbing from the bacterial surface by electron microscopy.7 Subsequent studies identified the Tol-Pal heteroprotein complex, which spans the Gram-negative cell envelope linking the outer membrane, peptidoglycan, and inner membrane layers, as a critical element for intra-envelope cross-linking during cell division.5 While a level of OMV release during cell division may be expected, interruption of the Tol-Pal complex by component deletion or mutation results in failure of daughter cells to separate and an increase in OMV production, consistent with a loss of outer membrane integrity and crosslinking.8-10
Building from this biophysical phenomenon during cell division, OMVs also play important and diverse roles for within bacterial communities and biofilms in nutrient acquisition, communication, and competition. Numerous extracellular membrane structures, including outer membrane vesicles, were observed in a cultured environmental biofilms taken from the surface of sedimentary rock.11 This variety of membrane vesicles underscores the complexity of the extracellular environment, as well as the diversity of functions of OMVs. In Bacteroides spp., careful analysis of OMV protein content identified OMV-specific acidic glycosidases and proteases proposed to function in carbohydrate liberation and nutrient acquisition for the local microbial community.12 OMVs polymerize and form physical connections between cells in the soil bacterium Myxococcus xanthus, suggesting the intriguing scenario of novel cell-cell connections to shuttle cellular materials within a biofilm.13 M. xanthus was previously shown to use OMVs to deliver alkaline phosphatase to lyse E. coli.14 The delivery of bio-active proteins for pathogenicity and environmental modification is of particular importance in the context of pathogenic bacteria - by far the most intensely studied group of bacteria, where several instances of OMV mediated delivery of virulence factors have been identified. Helicobacter pylori OMVs are enriched with the virulence factor HtrA, a protease secreted by numerous intestinal Gram-negative pathogens to interrupt the epithelial barrier.15 In the case of Salmonella enterica Typhimurium, several virulence factors have been linked to OMVs generated in conditions that replicate the intracellular portion of the lifecycle.16,17 Biophysical analysis of OMVs from Legionella pneumophila showed direct fusing of the bacterial vesicles with host liposomes and may facilitate cellular invasion and delivery of virulence factors to the host cell cytosol.18 Proteomic analysis of Vibrio cholera OMVs followed by selective gene deletion identified a decreased ability for biofilms formation upon deletion of the gene for the OMV protein degP.19
For any bacteria living in a mixed community and competing for resources – within an intestine, attached to a root system in the soil, or some other specified environmental niche – natural or pharmaceutical antimicrobial agents will provide selection pressure and challenge organismal fitness. OMVs serve an important role in countering these antimicrobials, acting as a decoy target away from the somatic cell, selectively removing the antibiotic from the surface of the cell, or shuttling antibiotic degrading enzymes into the milieu.1 For Pseudomonas syringae, a soil bacterium from shores of Lake Zub in Antarctica, OMVs provide protection against the antibiotics colistin and metillin, 2 antibiotics known to attack bacterial membranes.20 Similarly, OMVs isolated from E. coli MG1655 and then supplied to cultures of E. coli, Pseudomonas aeruginosa, and Acinetobacter redioresistens provided protection against the effects of membrane acting antibiotics.21 Further analysis of OMVs after incubation with the antibiotics revealed the membrane vesicles both sequester and degrade the antibiotics.21 In a similar fashion, an endogenous β-lactamase was found in OMVs from Bacteroides spp that provide protection to Salmonella enterica Typhimurium in susceptibility tests with the broad spectrum cephalosporin antibiotic, cefotaxime.22 This broadcast protection against antimicrobials by commensal microbiota provides interesting context when considering the true complexity of microbial population dynamics.
While the protective effects of OMVs against antimicrobials are important, the role that these vesicles play in immune stimulation and host–pathogen interaction is significant. In addition to the protein cargo already discussed, OMVs contain proteins from the inner and outer membrane, periplasm, and cytosol, lipids, DNA, peptidoglycan, and RNA.23 Numerous reports have documented the immune modulatory effects of OMVs on host cells, eliciting the production of cytokines, activating pattern recognition receptor (PRR) signaling pathways, disruption of epithelial barrier, and activation of dendritic cells and macrophages.23,24 This immune and cellular activity can be robust in the case of OMVs isolated from known pathogens, or it can facilitate immune tolerance and prevent inflammatory responses. Bacteroides fragilis presents the capsular protein polysaccharide A to dendritic cells via OMVs to suppress inflammation and maintain homeostasis within the intestine.25 Notably, a recent report identified OMVs from Pseudomonas aeruginosa as a delivery mechanism for sRNA to reduce IL-8 secretion in vitro, and cytokine secretion in vivo.26 For pathogenic bacteria, OMVs are receiving increased attention for their contribution to the immune modulatory properties and infectious life cycle. We have previously reported OMVs from Salmonella Typhimurium are immunologic facsimiles of the somatic cell and efficiently induce dendritic cell maturation and proinflammatory cytokine release.27 Importantly, inoculation of mice with S. Typhimurium OMVs generated a recall response and protection against future Salmonella infection.27 This effective immune stimulation has been seen with OMVs isolated from several other Gram-negative bacteria including E. coli, Shigella flexneri, and Neisseria meningitidis.28-32 Finally, OMVs can also serve as effective antigen delivery vehicles, stimulating dendritic maturation and both helper and cytotoxic T-cell responses against an otherwise non-immunogenic target such as ovalbumin.33
Further analysis of S. Typhimurium OMVs demonstrated that the quality or magnitude of the host cell response was dependent on the somatic bacterial cell gene expression.33 The S. Typhimurium life cycle can be generally discussed as either invasive or intracellular. While invasive, the bacteria are extra-cellular, flagellated, and express an immunogenic Lipid A and gene products from the Salmonella Pathogenicity Island 1 (SPI-1) which facilitate cellular invasion.34-36 Once the pathogen gains access to the intracellular niche, it up regulates genes from SPI-2 which code for products with reduced immunogenicity and which facilitate the cessation of lysosomal maturation, recruitment of nutrients, and formation of intracellular structures.37 Expression of SPI-2 is controlled by the master regulator gene PhoP.38,39 OMVs isolated from S. Typhimurium with a constitutively active PhoP were significantly less immunogeneic than those isolated from WT S. Typhimurium, failing to induce dendritic cell maturation or stimulate T-cell activation as effectively as the OMVs from the WT.33 Complementary to this observation, protein constituents of OMVs from S. Typhimurium grown in SPI-1 or SPI-2 inducing cell culture correlated to the underlying genetic expression events of the somatic bacterial cell.40 The expression-dependent content of OMVs provides exciting possibilities for rationally designed and tunable protein expression and adjuvant properties.41 In an in vivo infection model, OMVs were observed during the initial stages of invasion in several intracellular S. Typhimurium, supporting the notion that OMV release plays a role during infection.42 With the already thorough understanding of the infectious cycle of S. Typhimurium, alterations in OMV immunogenicity provides an interesting avenue for further refinement and discovery of host-pathogen interactions and mechanisms of pathogenicity.
Given the multitude of functions documented for OMVs from other work using deletion mutants or in vitro systems, the significance and impact they have on infection and host-pathogen interactions will be an important area of future research focus. Already OMV research has demonstrated an intrinsic adjuvant and antigenic advantage over heterologous antigens that may be incorporated or combined in artificial formulations, further revealing the versatility to enable choice of administration via the mucosal or parenteral routes.43 Additional refinement and detail to the mechanisms controlling OMV biogenesis and recruitment of biologically active molecules will augment our understanding of these membrane vesicles, how their cargo is manipulated, and their interactions with host cells or other microbes.
Disclosure of potential conflicts of interest
No potential conflicts of interest were disclosed.
Reference
- [1].Schwechheimer C, Kuehn MJ. Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions. Nat Rev Microbiol 2015; 13(10):605-19; PMID:26373371; http://dx.doi.org/ 10.1038/nrmicro3525 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].Cascales E, Bernadac A, Gavioli M, Lazzaroni JC, Lloubes R. Pal lipoprotein of Escherichia coli plays a major role in outer membrane integrity. J Bacteriol 2002; 184(3):754-9; PMID:11790745; http://dx.doi.org/ 10.1128/JB.184.3.754-759.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Park JS, Lee WC, Yeo KJ, Ryu KS, Kumarasiri M, Hesek D, Lee M, Mobashery S, Song JH, Kim SI, et al.. Mechanism of anchoring of OmpA protein to the cell wall peptidoglycan of the gram-negative bacterial outer membrane. FASEB J 2012; 26(1):219-28; PMID:21965596; http://dx.doi.org/ 10.1096/fj.11-188425 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Yeh YC, Comolli LR, Downing KH, Shapiro L, McAdams HH. The caulobacter Tol-Pal complex is essential for outer membrane integrity and the positioning of a polar localization factor. J Bacteriol 2010; 192(19):4847-58; PMID:20693330; http://dx.doi.org/ 10.1128/JB.00607-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Gerding MA, Ogata Y, Pecora ND, Niki H, de Boer PA. The trans-envelope Tol-Pal complex is part of the cell division machinery and required for proper outer-membrane invagination during cell constriction in E. coli. Mol Microbiol 2007; 63(4):1008-25; PMID:17233825; http://dx.doi.org/ 10.1111/j.1365-2958.2006.05571.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Roier S, Zingl FG, Cakar F, Durakovic S, Kohl P, Eichmann TO, Klug L, Gadermaier B, Weinzerl K, Prassl R, et al.. A novel mechanism for the biogenesis of outer membrane vesicles in Gram-negative bacteria. Nat Commun 2016; 7:10515; PMID:26806181; http://dx.doi.org/ 10.1038/ncomms10515 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Chatterjee SN, Das J. Electron microscopic observations on the excretion of cell-wall material by Vibrio cholerae. J Gen Microbiol 1967; 49(1):1-11; PMID:4168882; http://dx.doi.org/ 10.1099/00221287-49-1-1 [DOI] [PubMed] [Google Scholar]
- [8].Bernadac A, Gavioli M, Lazzaroni JC, Raina S, Lloubes R. Escherichia coli tol-pal mutants form outer membrane vesicles. J Bacteriol 1998; 180(18):4872-8; PMID:9733690 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Meury J, Devilliers G. Impairment of cell division in tolA mutants of Escherichia coli at low and high medium osmolarities. Biol Cell 1999; 91(1):67-75; PMID:10321024; http://dx.doi.org/ 10.1111/j.1768-322X.1999.tb01085.x [DOI] [PubMed] [Google Scholar]
- [10].Dubuisson JF, Vianney A, Hugouvieux-Cotte-Pattat N, Lazzaroni JC. Tol-Pal proteins are critical cell envelope components of Erwinia chrysanthemi affecting cell morphology and virulence. Microbiology 2005; 151(Pt 10):3337-47; PMID:16207916; http://dx.doi.org/ 10.1099/mic.0.28237-0 [DOI] [PubMed] [Google Scholar]
- [11].Włodarczyk A, Szymańska A, Bąkowska A, Skłodowska A, Matlakowska R. Extracellular membrane structures – a component of the epilithic biofilm on the Kupferschiefer black shale. Geomicrobiology Journal 2016; In Press. [Google Scholar]
- [12].Elhenawy W, Debelyy MO, Feldman MF. Preferential packing of acidic glycosidases and proteases into Bacteroides outer membrane vesicles. MBio 2014; 5(2):e00909-14; PMID:24618254; http://dx.doi.org/ 10.1128/mBio.00909-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Remis JP, Wei D, Gorur A, Zemla M, Haraga J, Allen S, Witkowska HE, Costerton JW, Berleman JE, Auer M. Bacterial social networks: structure and composition of Myxococcus xanthus outer membrane vesicle chains. Environ Microbiol 2014; 16(2):598-610; PMID:23848955; http://dx.doi.org/ 10.1111/1462-2920.12187 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14].Evans AG, Davey HM, Cookson A, Currinn H, Cooke-Fox G, Stanczyk PJ, Whitworth DE. Predatory activity of Myxococcus xanthus outer-membrane vesicles and properties of their hydrolase cargo. Microbiology 2012; 158(Pt 11):2742-52; PMID:22977088; http://dx.doi.org/ 10.1099/mic.0.060343-0 [DOI] [PubMed] [Google Scholar]
- [15].Hoy B, Geppert T, Boehm M, Reisen F, Plattner P, Gadermaier G, Sewald N, Ferreira F, Briza P, Schneider G, et al.. Distinct roles of secreted HtrA proteases from gram-negative pathogens in cleaving the junctional protein and tumor suppressor E-cadherin. J Biol Chem 2012; 287(13):10115-20; PMID:22337879; http://dx.doi.org/ 10.1074/jbc.C111.333419 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].Kitagawa R, Takaya A, Ohya M, Mizunoe Y, Takade A, Yoshida S, Isogai E, Yamamoto T. Biogenesis of Salmonella enterica serovar typhimurium membrane vesicles provoked by induction of PagC. J Bacteriol 2010; 192(21):5645-56; PMID:20802043; http://dx.doi.org/ 10.1128/JB.00590-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17].Yoon H, Ansong C, Adkins JN, Heffron F. Discovery of Salmonella virulence factors translocated via outer membrane vesicles to murine macrophages. Infect Immun 2011; 79(6):2182-92; PMID:21464085; http://dx.doi.org/ 10.1128/IAI.01277-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [18].Jager J, Keese S, Roessle M, Steinert M, Schromm AB. Fusion of Legionella pneumophila outer membrane vesicles with eukaryotic membrane systems is a mechanism to deliver pathogen factors to host cell membranes. Cell Microbiol 2015; 17(5):607-20; PMID:25363599; http://dx.doi.org/ 10.1111/cmi.12392 [DOI] [PubMed] [Google Scholar]
- [19].Altindis E, Fu Y, Mekalanos JJ. Proteomic analysis of Vibrio cholerae outer membrane vesicles. Proc Natl Acad Sci U S A 2014; 111(15):E1548-1556; PMID:24706774; http://dx.doi.org/ 10.1073/pnas.1403683111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Kulkarni HM, Swamy Ch V, Jagannadham MV. Molecular characterization and functional analysis of outer membrane vesicles from the antarctic bacterium Pseudomonas syringae suggest a possible response to environmental conditions. J Proteome Res 2014; 13(3):1345-58; PMID:24437924; http://dx.doi.org/ 10.1021/pr4009223 [DOI] [PubMed] [Google Scholar]
- [21].Kulkarni HM, Nagaraj R, Jagannadham MV. Protective role of E. coli outer membrane vesicles against antibiotics. Microbiol Res 2015; 181:1-7; PMID:26640046; http://dx.doi.org/ 10.1016/j.micres.2015.07.008 [DOI] [PubMed] [Google Scholar]
- [22].Stentz R, Horn N, Cross K, Salt L, Brearley C, Livermore DM, Carding SR. Cephalosporinases associated with outer membrane vesicles released by Bacteroides spp. protect gut pathogens and commensals against beta-lactam antibiotics. J Antimicrob Chemother 2015; 70(3):701-9; PMID:25433011; http://dx.doi.org/ 10.1093/jac/dku466 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Kaparakis-Liaskos M, Ferrero RL. Immune modulation by bacterial outer membrane vesicles. Nat Rev Immunol 2015; 15(6):375-87; PMID:25976515; http://dx.doi.org/ 10.1038/nri3837 [DOI] [PubMed] [Google Scholar]
- [24].Vanaja SK, Russo AJ, Behl B, Banerjee I, Yankova M, Deshmukh SD, Rathinam VA. Bacterial outer membrane vesicles mediate cytosolic localization of LPS and caspase-11 activation. Cell 2016; 165(5):1106-19; PMID:27156449; http://dx.doi.org/ 10.1016/j.cell.2016.04.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [25].Shen Y, Giardino Torchia ML, Lawson GW, Karp CL, Ashwell JD, Mazmanian SK. Outer membrane vesicles of a human commensal mediate immune regulation and disease protection. Cell Host Microbe 2012; 12(4):509-20; PMID:22999859; http://dx.doi.org/ 10.1016/j.chom.2012.08.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [26].Koeppen K, Hampton TH, Jarek M, Scharfe M, Gerber SA, Mielcarz DW, Demers EG, Dolben EL, Hammond JH, Hogan DA, et al.. A novel mechanism of host-pathogen interaction through sRNA in bacterial outer membrane vesicles. PLoS Pathog 2016; 12(6):e1005672; PMID:27295279; http://dx.doi.org/ 10.1371/journal.ppat.1005672 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [27].Alaniz RC, Deatherage BL, Lara JC, Cookson BT. Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J Immunol 2007; 179(11):7692-701; PMID:18025215; http://dx.doi.org/ 10.4049/jimmunol.179.11.7692 [DOI] [PubMed] [Google Scholar]
- [28].Chen DJ, Osterrieder N, Metzger SM, Buckles E, Doody AM, DeLisa MP, Putnam D. Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proc Natl Acad Sci U S A 2010; 107(7):3099-104; PMID:20133740; http://dx.doi.org/ 10.1073/pnas.0805532107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [29].Peeters CC, Rümke HC, Sundermann LC, Rouppe van der Voort EM, Meulenbelt J, Schuller M, Kuipers AJ, van der Ley P, Poolman JT. Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine 1996; 14(10):1009-15; PMID:8873396; http://dx.doi.org/ 10.1016/0264-410X(96)00001-1 [DOI] [PubMed] [Google Scholar]
- [30].Arigita C, Jiskoot W, Westdijk J, van Ingen C, Hennink WE, Crommelin DJ, Kersten GF. Stability of mono- and trivalent meningococcal outer membrane vesicle vaccines. Vaccine 2004; 22(5-6):629-42; PMID:14741154; http://dx.doi.org/ 10.1016/j.vaccine.2003.08.027 [DOI] [PubMed] [Google Scholar]
- [31].Camacho AI, Irache JM, de Souza J, Sanchez-Gomez S, Gamazo C. Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice. Vaccine 2013; 31(32):3288-94; PMID:23727423; http://dx.doi.org/ 10.1016/j.vaccine.2013.05.020 [DOI] [PubMed] [Google Scholar]
- [32].Camacho AI, de Souza J, Sánchez-Gómez S, Pardo-Ros M, Irache JM, Gamazo C. Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice. Vaccine 2011; 29(46):8222-9; PMID:21911022; http://dx.doi.org/ 10.1016/j.vaccine.2011.08.121 [DOI] [PubMed] [Google Scholar]
- [33].Laughlin RC, Mickum M, Rowin K, Adams LG, Alaniz RC. Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens. Vaccine 2015; 33(38):5012-9; PMID:26001432; http://dx.doi.org/ 10.1016/j.vaccine.2015.05.014 [DOI] [PubMed] [Google Scholar]
- [34].Zhang S, Adams LG, Nunes J, Khare S, Tsolis RM, Bäumler AJ. Secreted effector proteins of Salmonella enterica serotype typhimurium elicit host-specific chemokine profiles in animal models of typhoid fever and enterocolitis. Infect Immun 2003; 71(8):4795-803; PMID:12874363; http://dx.doi.org/ 10.1128/IAI.71.8.4795-4803.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [35].Zhang S, Kingsley RA, Santos RL, Andrews-Polymenis H, Raffatellu M, Figueiredo J, Nunes J, Tsolis RM, Adams LG, Bäumler AJ. Molecular pathogenesis of Salmonella enterica serotype typhimurium-induced diarrhea. Infect Immun 2003; 71(1):1-12; PMID:12496143; http://dx.doi.org/ 10.1128/IAI.71.1.1-12.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [36].Lawhon SD, Khare S, Rossetti CA, Everts RE, Galindo CL, Luciano SA, Figueiredo JF, Nunes JE, Gull T, Davidson GS, et al.. Role of SPI-1 secreted effectors in acute bovine response to Salmonella enterica Serovar Typhimurium: a systems biology analysis approach. PloS One 2011; 6(11):e26869; PMID:22096503; http://dx.doi.org/ 10.1371/journal.pone.0026869 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [37].LaRock DL, Chaudhary A, Miller SI. Salmonellae interactions with host processes. Nat Rev Microbiol 2015; 13(4):191-205; PMID:25749450; http://dx.doi.org/ 10.1038/nrmicro3420 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [38].Fass E, Groisman EA. Control of Salmonella pathogenicity island-2 gene expression. Curr Opin Microbiol 2009; 12(2):199-204; PMID:19264535; http://dx.doi.org/ 10.1016/j.mib.2009.01.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [39].Bijlsma JJ, Groisman EA. The PhoP/PhoQ system controls the intramacrophage type three secretion system of Salmonella enterica. Mol Microbiol 2005; 57(1):85-96; PMID:15948951; http://dx.doi.org/ 10.1111/j.1365-2958.2005.04668.x [DOI] [PubMed] [Google Scholar]
- [40].Bai D, Nakao R, Ito A, Uematsu H, Senpuku H. Immunoreactive antigens recognized in serum samples from mice intranasally immunized with Porphyromonas gingivalis outer membrane vesicles. Pathog Dis 2015; 73(3); PMID:25743469; http://dx.doi.org/ 10.1093/femspd/ftu006 [DOI] [PubMed] [Google Scholar]
- [41].Baker JL, Chen L, Rosenthal JA, Putnam D, DeLisa MP. Microbial biosynthesis of designer outer membrane vesicles. Curr Opin Biotechnol 2014; 29:76-84; PMID:24667098; http://dx.doi.org/ 10.1016/j.copbio.2014.02.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [42].Laughlin RC, Knodler LA, Barhoumi R, Payne HR, Wu J, Gomez G, Pugh R, Lawhon SD, Bäumler AJ, Steele-Mortimer O, et al.. Spatial segregation of virulence gene expression during acute enteric infection with Salmonella enterica serovar Typhimurium. MBio 2014; 5(1):e00946-13; PMID:24496791; http://dx.doi.org/ 10.1128/mBio.00946-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [43].Acevedo R, Fernández S, Zayas C, Acosta A, Sarmiento ME, Ferro VA, Rosenqvist E, Campa C, Cardoso D, Garcia L, et al.. Bacterial outer membrane vesicles and vaccine applications. Front Immunol 2014; 5:121; PMID:24715891; http://dx.doi.org/ 10.3389/fimmu.2014.00121 [DOI] [PMC free article] [PubMed] [Google Scholar]
